Abstract:Progeroid laminopathies are accelerated aging syndromes caused by defects in nuclear envelope proteins. Accordingly, mutations in the LMNA gene and functionally related genes have been described to cause HGPS (Hutchinson-Gilford progeria syndrome), MAD (mandibuloacral dysplasia) or RD (restrictive dermopathy). Functional studies with animal and cellular models of these syndromes have facilitated the identification of the molecular alterations and regulatory pathways involved in progeria development. We have recently described a novel regulatory pathway involving miR-29 and p53 tumour suppressor which has provided valuable information on the molecular components orchestrating the response to nuclear damage stress. Furthermore, by using progeroid mice deficient in ZMPSTE24 (zinc metalloprotease STE24 homologue) involved in lamin A maturation, we have demonstrated that, besides these abnormal cellular responses to stress, dysregulation of the somatotropic axis is responsible for some of the alterations associated with progeria. Consistent with these observations, pharmacological restoration of the somatotroph axis in these mice delays the onset of their progeroid features, significantly extending their lifespan and supporting the importance of systemic alterations in progeria progression. Finally, we have very recently identified a novel progeroid syndrome with distinctive features from HGPS and MAD, which we have designated NGPS (Néstor-Guillermo progeria syndrome) (OMIM #614008). This disorder is caused by a mutation in BANF1, a gene encoding a protein with essential functions in the assembly of the nuclear envelope, further illustrating the importance of the nuclear lamina integrity for human health and providing additional support to the study of progeroid syndromes as a valuable source of information on human aging.

Mechanisms of Genome Instability in Hutchinson-Gilford Progeria

The Pathogenic Mechanisms and Therapeutic Strategies of Hutchinson-Gilford Progeria Syndrome

Molecular insights into the premature aging disease progeria

Correlated Alterations in Genome Organization, Histone Methylation, and DNA–lamin A/C Interactions in Hutchinson-Gilford Progeria Syndrome

A Lamin A Protein Isoform Overexpressed in Hutchinson–Gilford Progeria Syndrome Interferes with Mitosis in Progeria and Normal Cells

Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS)

Progerin Can Induce DNA Damage in the Absence of Global Changes in Replication or Cell Proliferation

Mechanisms Controlling the Smooth Muscle Cell Death in Progeria Via Down-Regulation of Poly(Adp-Ribose) Polymerase 1

Mechanotransduction of the vasculature in Hutchinson-Gilford Progeria Syndrome

Cell aging caused by prelamin A mutation

Progerin and Telomere Dysfunction Collaborate to Trigger Cellular Senescence in Normal Human Fibroblasts

Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway

Hutchinson–Gilford Progeria Syndrome: A Premature Aging Disease

Research Progress on Lamin and Hutchinson-Gilford Progeria Syndrome

Progeria-based vascular model identifies networks associated with cardiovascular aging and disease

Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging

Accelerated aging syndromes, are they relevant to normal human aging?

Heterochromatin loss as a determinant of progerin‐induced DNA damage in Hutchinson–Gilford Progeria

Vascular senescence in progeria: role of endothelial dysfunction

Cell autonomous and systemic factors in progeria development

A Therapeutic Target for Vascular Protection in Hutchinson–Gilford Progeria Syndrome